How AI search views your company.
AI Company Market Strategy Reports powered by LLM Authority Index. Each report shows how AI systems surface, compare, and recommend your specific brand — with remediation priorities for AEO, citation architecture, and SEO visibility.
Independent market intelligence - Not case studies
SHOWING 1–9 OF 719
PolyPeptide Group AI Market Strategy Report — Peptide API Manufacturing
PolyPeptide Group’s June 2026 benchmark shows strong recognition in peptide API manufacturing, but weaker conversion from mention to recommendation.
- Type
- AI Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis
CSBio AI Market Strategy Report — Peptide API Manufacturing
CSBio shows limited visibility in peptide API manufacturing, with one valid recommendation and no top-3 placements.
- Type
- AI Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis
CPC Scientific AI Market Strategy Report — Peptide API Manufacturing
CPC Scientific appears in peptide API manufacturing benchmarks, with broad mention presence but limited shortlist conversion.
- Type
- AI Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis
CordenPharma Peptides AI Market Strategy Report — Peptide API Manufacturing
CordenPharma Peptides is visible in peptide API manufacturing queries but does not reach recommendation-stage placement.
- Type
- AI Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis
Biosynth Peptide Division AI Market Strategy Report — Peptide API Manufacturing
See where Biosynth Peptide Division appears, earns recommendations, and loses visibility across AI search results for Peptide API Manufacturing.
- Type
- AI Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis
AmbioPharm AI Market Strategy Report — Peptide API Manufacturing
AmbioPharm is benchmarked against peptide manufacturing competitors across six AI platforms, showing strong shortlist visibility, limited rank-1 control, and.
- Type
- AI Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis
Phoenix Pharmaceuticals AI Market Strategy Report — Peptide Suppliers
Phoenix Pharmaceuticals appears broadly across AI answers in the peptide supplier category, with strong positive sentiment and 52 valid recommendations.
- Type
- AI Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis
Peptides Source AI Market Strategy Report — Peptide Suppliers
Peptides Source appears in AI answers across peptide supplier prompts, but it does not reach top-3 or rank-1 recommendations.
- Type
- AI Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis
Peptide Tech AI Market Strategy Report — Peptide Suppliers
See where Peptide Tech appears, earns recommendations, and loses visibility across AI search results for Peptide Suppliers.
- Type
- AI Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis
Bring this to your own market
Want the same lens applied to your category or company?
Request an AI Visibility Audit and we'll show you where AI systems are recommending — and overlooking — your brand, and what to fix first.